利用CRISPR/Cas9技术从视网膜色素变性患者身上获得基因校正的等基因人类iPS细胞系(CSUASOi006-A-2

IF 0.8 4区 医学 Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Hang Chen , Yuqin Liang , Yuan Liang , Yuexi Chen , Xiaoxue Li , Ruting Zhang , Chunwen Duan , Wenwei Li , Zekai Cui , Jianing Gu , Chengcheng Ding , Xihao Sun , Jiansu Chen
{"title":"利用CRISPR/Cas9技术从视网膜色素变性患者身上获得基因校正的等基因人类iPS细胞系(CSUASOi006-A-2","authors":"Hang Chen ,&nbsp;Yuqin Liang ,&nbsp;Yuan Liang ,&nbsp;Yuexi Chen ,&nbsp;Xiaoxue Li ,&nbsp;Ruting Zhang ,&nbsp;Chunwen Duan ,&nbsp;Wenwei Li ,&nbsp;Zekai Cui ,&nbsp;Jianing Gu ,&nbsp;Chengcheng Ding ,&nbsp;Xihao Sun ,&nbsp;Jiansu Chen","doi":"10.1016/j.scr.2025.103727","DOIUrl":null,"url":null,"abstract":"<div><div>Retinitis pigmentosa (RP) is a heterogeneous group of hereditary eye disorders characterized by a progressive degeneration of the light-sensing photoreceptor cells in the retina. Currently, there are no effective treatments. In a previous study, we generated a human induced pluripotent stem (iPS) cell line (CSUASOi006-A) from an RP patient carrying a PRPF8 (c.C5792T) mutation. In this study, we corrected the c.5792C &gt; T mutation in the PRPF8 gene using CRISPR/Cas9 technology and generated an isogenic control cell line (CSUASOi006-A-2). This provides an important cellular resource for RP research.</div></div>","PeriodicalId":21843,"journal":{"name":"Stem cell research","volume":"86 ","pages":"Article 103727"},"PeriodicalIF":0.8000,"publicationDate":"2025-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Generation of a gene-corrected isogenic human iPS cell line (CSUASOi006-A-2) from a retinitis pigmentosa patient using CRISPR/Cas9 technology\",\"authors\":\"Hang Chen ,&nbsp;Yuqin Liang ,&nbsp;Yuan Liang ,&nbsp;Yuexi Chen ,&nbsp;Xiaoxue Li ,&nbsp;Ruting Zhang ,&nbsp;Chunwen Duan ,&nbsp;Wenwei Li ,&nbsp;Zekai Cui ,&nbsp;Jianing Gu ,&nbsp;Chengcheng Ding ,&nbsp;Xihao Sun ,&nbsp;Jiansu Chen\",\"doi\":\"10.1016/j.scr.2025.103727\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Retinitis pigmentosa (RP) is a heterogeneous group of hereditary eye disorders characterized by a progressive degeneration of the light-sensing photoreceptor cells in the retina. Currently, there are no effective treatments. In a previous study, we generated a human induced pluripotent stem (iPS) cell line (CSUASOi006-A) from an RP patient carrying a PRPF8 (c.C5792T) mutation. In this study, we corrected the c.5792C &gt; T mutation in the PRPF8 gene using CRISPR/Cas9 technology and generated an isogenic control cell line (CSUASOi006-A-2). This provides an important cellular resource for RP research.</div></div>\",\"PeriodicalId\":21843,\"journal\":{\"name\":\"Stem cell research\",\"volume\":\"86 \",\"pages\":\"Article 103727\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2025-04-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Stem cell research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1873506125000777\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stem cell research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1873506125000777","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

色素性视网膜炎(RP)是一种异质性的遗传性眼部疾病,其特征是视网膜中感光细胞的进行性变性。目前还没有有效的治疗方法。在之前的研究中,我们从一名携带PRPF8 (c.c c5792t)突变的RP患者身上获得了一株人诱导多能干细胞(CSUASOi006-A)。在本研究中,我们修正了c.5792C >;利用CRISPR/Cas9技术进行PRPF8基因T突变,生成等基因对照细胞系(CSUASOi006-A-2)。这为RP研究提供了重要的细胞资源。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Generation of a gene-corrected isogenic human iPS cell line (CSUASOi006-A-2) from a retinitis pigmentosa patient using CRISPR/Cas9 technology
Retinitis pigmentosa (RP) is a heterogeneous group of hereditary eye disorders characterized by a progressive degeneration of the light-sensing photoreceptor cells in the retina. Currently, there are no effective treatments. In a previous study, we generated a human induced pluripotent stem (iPS) cell line (CSUASOi006-A) from an RP patient carrying a PRPF8 (c.C5792T) mutation. In this study, we corrected the c.5792C > T mutation in the PRPF8 gene using CRISPR/Cas9 technology and generated an isogenic control cell line (CSUASOi006-A-2). This provides an important cellular resource for RP research.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Stem cell research
Stem cell research 生物-生物工程与应用微生物
CiteScore
2.20
自引率
8.30%
发文量
338
审稿时长
55 days
期刊介绍: Stem Cell Research is dedicated to publishing high-quality manuscripts focusing on the biology and applications of stem cell research. Submissions to Stem Cell Research, may cover all aspects of stem cells, including embryonic stem cells, tissue-specific stem cells, cancer stem cells, developmental studies, stem cell genomes, and translational research. Stem Cell Research publishes 6 issues a year.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信